{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:29:38Z","timestamp":1777307378910,"version":"3.51.4"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"suppl_5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11,15]]},"DOI":"10.1093\/cid\/civ593","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T00:33:10Z","timestamp":1447115590000},"page":"S391-S395","source":"Crossref","is-referenced-by-count":21,"title":["From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project"],"prefix":"10.1093","volume":"61","author":[{"given":"M. Teresa","family":"Aguado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Jodar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Granoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Rabinovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costante","family":"Ceccarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon W.","family":"Perkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,11,9]]},"reference":[{"key":"key\n\t\t\t\t20171013234154_CIV593C1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0035-9203(99)90106-2","article-title":"Manson lecture. Meningococcal meningitis in Africa","volume":"93","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20171013234154_CIV593C2","first-page":"313","article-title":"Epidemic meningitis in Africa, 1997","volume":"72","author":"World Health Organization","year":"1997","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20171013234154_CIV593C3","first-page":"499","article-title":"Epidemiology of bacterial meningitis in Niamey, Niger, 1981\u201396","volume":"77","year":"1999","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20171013234154_CIV593C4","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00006454-199912000-00005","article-title":"Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa","volume":"18","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20171013234154_CIV593C5","first-page":"297","article-title":"World Health Organization. Group A and C meningococcal vaccines, WHO position paper","volume":"74","year":"1999","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20171013234154_CIV593C6","first-page":"64","article-title":"Position paper on Haemophilus influenzae type b conjugate vaccines","volume":"73","author":"Global Program for Vaccines and Immunization","year":"1998","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20171013234154_CIV593C7","first-page":"1018","article-title":"Licensure of a meningococcal conjugate vaccine for children aged 2 through 10 years and updated booster dose guidance for adolescents and other persons at increased risk for meningococcal disease","volume":"60","author":"Advisory Committee on Immunization Practices (ACIP)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171013234154_CIV593C8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","article-title":"Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity","volume":"17","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20171013234154_CIV593C9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00006454-200002000-00013","article-title":"Safety and immunogenicity of three doses of a Neisseria meningitidis A+C diphtheria conjugate vaccine in infants from Niger","volume":"19","year":"2000","journal-title":"Pedriatr Infect Dis J"},{"key":"key\n\t\t\t\t20171013234154_CIV593C10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/infdis\/171.3.632","article-title":"A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants","volume":"171","year":"1995","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013234154_CIV593C11","article-title":"World Health Organization meeting report. Joint recommendations for the development and introduction of conjugate vaccines against meningococcal disease in the African and Eastern Mediterranean regions\u2014annex to WHO meeting report, April 2000"},{"key":"key\n\t\t\t\t20171013234154_CIV593C12","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0140-6736(03)13494-0","article-title":"Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries","volume":"361","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171013234154_CIV593C13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1377\/hlthaff.2011.0328","article-title":"Eliminating epidemic group A meningococcal meningitis in Africa through a new vaccine","volume":"30","year":"2011","journal-title":"Health Aff"},{"issue":"suppl 5","key":"key\n\t\t\t\t20171013234154_CIV593C14","first-page":"S396","article-title":"The evolution of the meningitis vaccine project","volume":"61","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/61\/suppl_5\/S391\/20914252\/civ593.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T03:42:01Z","timestamp":1507952521000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/61\/suppl_5\/S391\/418186\/From-Epidemic-Meningitis-Vaccines-for-Africa-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,9]]},"references-count":14,"journal-issue":{"issue":"suppl_5","published-online":{"date-parts":[[2015,11,9]]},"published-print":{"date-parts":[[2015,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/civ593","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,11,15]]},"published":{"date-parts":[[2015,11,9]]}}}